NEO
Price
$16.59
Change
+$0.19 (+1.16%)
Updated
Oct 23, 04:59 PM (EDT)
Capitalization
2.11B
5 days until earnings call
Intraday BUY SELL Signals
SHC
Price
$18.09
Change
-$0.04 (-0.22%)
Updated
Oct 23, 04:59 PM (EDT)
Capitalization
5.17B
11 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NEO vs SHC

NEO vs SHC Comparison Chart in %
View a ticker or compare two or three
VS
NEO vs. SHC commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a Hold and SHC is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for NEO with price predictions
Oct 22, 2026

Aroon Indicator for NEO shows an upward move is likely

NEO's Aroon Indicator triggered a bullish signal on September 30, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 189 similar instances where the Aroon Indicator showed a similar pattern. In 155 of the 189 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 59 cases where NEO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on NEO as a result. In 65 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

Following a +3.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where NEO advanced for three days, in 215 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

NEO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for NEO moved out of overbought territory on September 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 28 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Moving Average Convergence Divergence Histogram (MACD) for NEO turned negative on September 25, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 37 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.

NEO moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NEO crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.680) is normal, around the industry mean (66.046). P/E Ratio (-42.026) is within average values for comparable stocks, (2.422). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (3.189) is also within normal values, averaging (9.775).

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. NEO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

A.I.Advisor
a Summary for SHC with price predictions
Oct 22, 2026

Momentum Indicator for SHC turns positive, indicating new upward trend

SHC saw its Momentum Indicator move above the 0 level on October 22, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned positive. In 57 of the 79 cases, the stock moved higher in the following days. The odds of a move higher are at 72%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 62 cases where SHC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.

The Moving Average Convergence Divergence (MACD) for SHC just turned positive on October 22, 2026. Looking at past instances where SHC's MACD turned positive, the stock continued to rise in 26 of 38 cases over the following month. The odds of a continued upward trend are 68%.

Following a +0.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where SHC advanced for three days, in 187 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

SHC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

SHC moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SHC crossed bearishly below the 50-day moving average on September 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

The Aroon Indicator for SHC entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating fairly steady price growth. SHC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.773) is normal, around the industry mean (66.046). P/E Ratio (31.807) is within average values for comparable stocks, (2.422). Projected Growth (PEG Ratio) (1.313) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (4.587) is also within normal values, averaging (9.775).

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

FUNDAMENTALS RATINGS
NEO vs SHC: Fundamental Ratings
NEO
SHC
OUTLOOK RATING
1..100
1115
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9235
PRICE GROWTH RATING
1..100
3750
P/E GROWTH RATING
1..100
5996
SEASONALITY SCORE
1..100
4118

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (27) in the Medical Or Nursing Services industry is somewhat better than the same rating for SHC (77) in the null industry. This means that NEO’s stock grew somewhat faster than SHC’s over the last 12 months.

NEO's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as SHC (100) in the null industry. This means that NEO’s stock grew similarly to SHC’s over the last 12 months.

SHC's SMR Rating (35) in the null industry is somewhat better than the same rating for NEO (92) in the Medical Or Nursing Services industry. This means that SHC’s stock grew somewhat faster than NEO’s over the last 12 months.

NEO's Price Growth Rating (37) in the Medical Or Nursing Services industry is in the same range as SHC (50) in the null industry. This means that NEO’s stock grew similarly to SHC’s over the last 12 months.

NEO's P/E Growth Rating (59) in the Medical Or Nursing Services industry is somewhat better than the same rating for SHC (96) in the null industry. This means that NEO’s stock grew somewhat faster than SHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEOSHC
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 11 days ago
68%
Declines
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 5 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
62%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (NEO: $16.39 vs. SHC: $18.13)
Brand notoriety: NEO and SHC are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEO: 73% vs. SHC: 134%
Market capitalization -- NEO: $2.11B vs. SHC: $5.17B
NEO [@Medical Specialties] is valued at $2.11B. SHC’s [@Medical Specialties] market capitalization is $5.17B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical Specialties] industry is $21.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 1 FA rating(s) are green while SHC’s FA Score has 0 green FA rating(s).

  • NEO’s FA Score: 1 green, 4 red.
  • SHC’s FA Score: 0 green, 5 red.
According to our system of comparison, NEO is a better buy in the long-term than SHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 5 TA indicator(s) are bullish while SHC’s TA Score has 5 bullish TA indicator(s).

  • NEO’s TA Score: 5 bullish, 5 bearish.
  • SHC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SHC is a better buy in the short-term than NEO.

Price Growth

NEO (@Medical Specialties) experienced а -4.99% price change this week, while SHC (@Medical Specialties) price change was +0.33% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.84%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +42.19%.

Reported Earning Dates

NEO is expected to report earnings on Oct 28, 2026.

SHC is expected to report earnings on Nov 03, 2026.

Industries' Descriptions

@Medical Specialties (+1.84% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
NEO
Daily Signal:
Gain/Loss:
SHC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with NTRA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then NTRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
-3.81%
NTRA - NEO
54%
Loosely correlated
-2.91%
ADPT - NEO
52%
Loosely correlated
-3.63%
CSTL - NEO
47%
Loosely correlated
-3.43%
RVTY - NEO
46%
Loosely correlated
+0.48%
SHC - NEO
44%
Loosely correlated
+2.03%
More

SHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, SHC has been loosely correlated with RVTY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SHC jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHC
1D Price
Change %
SHC100%
+2.03%
RVTY - SHC
53%
Loosely correlated
+0.48%
TMO - SHC
52%
Loosely correlated
-2.52%
CRL - SHC
52%
Loosely correlated
-1.51%
A - SHC
50%
Loosely correlated
-2.17%
MTD - SHC
49%
Loosely correlated
+0.40%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RJVI24.550.20
+0.83%
RJ Eagle Vertical Income ETF (RJVI)
VALG13.49N/A
N/A
Leverage Shares 2X Long VALE Daily ETF (VALG)
ITDB34.89-0.06
-0.18%
iShares LifePath Target Date 2030 ETF (ITDB)
AAAA30.16-0.31
-1.02%
Amplius Aggressive Asset Allocation ETF (AAAA)
TGRW46.02-1.44
-3.03%
T. Rowe Price Growth Stock ETF (TGRW)